PRMT5 and Miyoshi myopathy: Our analysis revealed that 43% of the MM samples expressed PRMT5 in both nuclei and cytoplasms (Figure 1, D and E), 19% and 31% showed a cytoplasmic (Figure 1C) or nuclear PRMT5 localization, respectively, and only 7% did not express PRMT5.